Epilepsiezentrum Berlin Brandenburg
- Address
- Fanningerstrasse 32, Lichtenberg, 10365 Berlin, Germany
Epilepsiezentrum Berlin Brandenburg - Specialized Epilepsy Research Center
The Epilepsiezentrum Berlin Brandenburg is a dedicated epilepsy research center with specialized expertise in evaluating novel therapeutic approaches for seizure disorders. The center focuses on conducting rigorous clinical investigations to advance treatment options for patients living with epilepsy, with particular emphasis on improving seizure control and quality of life through innovative pharmacological interventions.
- Clinical trials of novel antiepileptic medications as adjunctive therapy for focal epilepsy
- Safety and tolerability assessments of investigational antiseizure medications (ASMs)
- Efficacy evaluation of treatments for adult patients with partial onset seizures
The center specializes in focal (partial onset) epilepsy research, conducting comprehensive studies that evaluate both short-term and long-term outcomes of new treatments. Their clinical trials infrastructure supports multicenter investigations with open-label extension phases, allowing researchers to gather extensive data on the safety profile and therapeutic benefits of emerging antiseizure medications in patients taking multiple concurrent treatments.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 8 therapeutic areas and 15 of 22 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
- 1AstraZeneca AB2active
lock +9 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB2trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Epilepsiezentrum Berlin Brandenburg
lock Showing 1 of 14 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| C3651021: A PHASE 2b/3, RANDOMIZED, DOUBLE-BLIND STUDY TO INVESTIGATE THE EFFICACY, SAFETY, AND TOLERABILITY OF PONSEGROMAB (PF-06946860) COMPARED WITH PLACEBO BOTH WITH BACKGROUND FIRST-LINE CHEMOTHERAPY IN ADULT PARTICIPANTS WITH CACHEXIA AND METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA | Pfizer Inc. | Phase IV | Not Yet Recruiting | May 2026 | — |
IMP list
lock Showing 1 of 22 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Gemcitabine | 3 | Unknown | 2026-04-13 | 2026-04-13 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.